WHAT IS SOFTWAVE?
TRT/MTS SoftWave is a noninvasive therapeutic device that uses a patented, breakthrough shock wave technology delivering unmatched benefits in sports medicine and regenerative care. It works rapidly to relieve chronic pain and boost recovery times with lasting results, truly transformative rather than incremental.
Regenerate SoftWave Therapy is FDA-cleared, non-invasive, and drug-free, targeting inflammation, chronic pain, diabetes, and joint conditions.
According to the National Center for Biotechnology Information (NCBI), “Shockwave (SoftWave) therapy significantly reduces pain from tendinopathies and improves function and quality of life. It may be the first choice due to its safety and effectiveness.”
This therapy employs the FDA-cleared OrthoGold100 SoftWave™ device, used successfully in Europe for over ten years. SoftWave stimulates new stem cell growth, enhances circulation, breaks down scar tissue and calcifications, and reduces inflammation.
Request an AppointmentMost patients notice relief within their first 15-minute session and typically complete treatment in about six visits. Many report a 50% pain reduction after just one or two treatments.
Clinical data shows Regenerate SoftWave Therapy offers a remarkable 91% success rate, delivering a drug-free, injection-free, and surgery-free path to ending pain.
The TRT/MTS OrthoGold 100 SoftWave device is the only unfocused ESWT technology available in North America, scientifically validated to:
- Immediately suppress inflammation at the treatment site by modulating signaling molecules like TLR3 and nitric oxide, resulting in rapid, lasting relief of chronic pain and release of adhesions. Improved range of motion is common.
- Enhance blood flow sustainably by releasing VEGF and other growth factors and cytokines, boosting ATP production, and promoting neoangiogenesis and vasculogenesis. The therapy is proven to activate the body’s own stem cells.
SoftWave also provides biofeedback to accurately identify pain origin points, improving treatment precision.
Usually, just one to three gentle, noninvasive sessions are sufficient. Unlike other methods, SoftWave does not rely on microtrauma but gently stimulates healing cascades through cellular microvesicle shedding.
SoftWave is patented, unique, and profound. Its unfocused electrohydraulic design offers several key advantages:
- 100% atraumatic to tissues and cells
- Near-immediate pain relief in many cases
- Long-lasting improvements in blood flow
- A treatment zone thousands of times larger than focused or planar devices
- Greater efficiency and effectiveness
- Typically requires three or fewer sessions
- Real-time biofeedback enables precise targeting without imaging or trigger points
- Transformational healing rather than incremental gains
- The only unfocused Electrohydraulic ESWT FDA-cleared in North America
SoftWave is trusted by professional sports teams, leading medical institutions, and many sports legends, active and retired. Thousands have benefited from faster healing and recovery.
ALL SHOCK WAVE THERAPIES ARE NOT CREATED EQUAL
Referring to this treatment as “SoftWave therapy” helps clear confusion caused by many devices marketed as “shock wave therapy” that do not generate true shock waves, often resulting in poor outcomes.
Understanding types of shock wave therapies:
There are two main categories:
- Extracorporeal Shock Wave Therapy (ESWT)
- Radial Pulse Therapy (also called rSWT, rESWT, RPT, EPAT), which produces sound waves rather than true shock waves and treats fewer conditions.
Within ESWT there are two types:
- Focused ESWT – relies on microtrauma, small treatment zones, many sessions, and less scientific validation. It includes:
- Electrohydraulic (most efficient and effective)
- Piezoelectric (focused with limited published science)
- Electromagnetic (low energy, few studies)
- Unfocused ESWT (SoftWave) – patented by TRT, uses electrohydraulic waves, is non-traumatic, covers a much larger area, has extensive scientific backing, and promotes anti-inflammation, stem cell activation, vascularization, healing, and pathogen elimination.
DEVICES THAT CLAIM SHOCK WAVE BUT ARE NOT
Ballistic shockwave devices do not create true shock waves despite marketing claims.
Radial shock wave therapy does not produce shock waves at current pressure levels.
SOFTWAVE BACKED BY SCIENCE
The patented TRT/MTS SoftWave technology stands apart with extensive peer-reviewed studies validating its molecular and cellular healing mechanisms. Beware of other brands citing unrelated studies.
THE BEST KEPT SECRET IN PROFESSIONAL SPORTS
For years, SoftWave has quietly helped top sports medicine clinicians accelerate recovery for star athletes. Now, it’s gaining recognition as a key advantage in helping players return to the field faster and stronger.
PATENT AND FDA CLEARANCE
Patent details: View Patent
FDA Clearance: View FDA Clearance
SUPPORTING RESEARCH ON UNFOCUSED ESWT
ESWT is widely used non-surgically for its pro-angiogenic and anti-inflammatory effects, promoting tissue homeostasis and self-healing through stem cell proliferation, neovascularization, and immune system modulation.
Studies also highlight its role in muscle performance improvement and injury prevention in both athletes and aging populations.